Cross-Presentation, Dendritic Cells, Tolerance and Immunity

Dendritic cells and the control of immunity

Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,496

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. J. (1997) · Nature · doi:10.1038/41131 · Cited by 6,137

Tolerance, Danger, and the Extended Family

Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848

T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions

Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.

Sallusto, F., Cella, M., Danieli, C., & Lanzavecchia, A. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.2.389 · Cited by 2,501

IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE

Steinman, R. M., & Cohn, Z. A. (1973) · The Journal of Experimental Medicine · doi:10.1084/jem.137.5.1142 · Cited by 2,443

Innate Immunity: The Virtues of a Nonclonal System of Recognition

Medzhitov, R., & Janeway, C. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80412-2 · Cited by 2,434

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

Ridge, J. P., Rosa, F. D., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,360

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,350

Immunomodulation with antibodies: clinical application in ovarian cancer and other malignancies

Nicodemus, C. F., Schultes, B. C., & Hamilton, B. L. (2002) · Expert Review of Vaccines · doi:10.1586/14760584.1.1.35 · Cited by 13

Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis

Rongvaux, A., Shea, R. J., Mulks, M. H., Gigot, D., Urbain, J., Léo, O., & Andris, F. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200211)32:11 · Cited by 551

Thymic Expression of a Gastritogenic Epitope Results in Positive Selection of Self-Reactive Pathogenic T Cells

Laurie, K., Gruta, N. L. L., Koch, N., van Driel, I. R., & Gleeson, P. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.5994 · Cited by 13

In Vivo Generation of Dendritic Cells by Intramuscular Codelivery of FLT3 Ligand and GM-CSF Plasmids

Peretz, Y., Zhou, Z., Halwani, F., & Prud’homme, G. J. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0677 · Cited by 13

T Cell Memory

Tan, J. T., & Surh, C. D. (2006) · Springer eBooks · doi:10.1007/3-540-32636-7_4 · Cited by 13

Functional Specialization of Dendritic Cell Subsets

Heidkamp, G. F., Lehmann, C. H. K., Heger, L., Baransk, A., Hoffmann, A., Lühr, J. J., & Dudziak, D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30076-1 · Cited by 13

Poly (I:C) enhances the anti-tumor activity of canine parvovirus NS1 protein by inducing a potent anti-tumor immune response

Gupta, S. K., Yadav, P. K., Tiwari, A. K., Gandham, R. K., & Sahoo, A. P. (2016) · Tumor Biology · doi:10.1007/s13277-016-5093-z · Cited by 12

Immune‐mediated antitumor effect of a transplanted lymph node

Maeda, T., Hayashi, T., Furukawa, H., Iwasaki, D., Ishikawa, K., Funayama, E., Murao, N., Osawa, M., Oyama, A., & Yamamoto, Y. (2018) · International Journal of Cancer · doi:10.1002/ijc.31414 · Cited by 12

Influenza A virus infection‐induced macroautophagy facilitates MHC class II‐restricted endogenous presentation of an immunodominant viral epitope

Deng, J., Lu, C., Liu, C., Oveissi, S., Fairlie, W. D., Lee, E. F., Bilsel, P., Puthalakath, H., & Chen, W. (2020) · FEBS Journal · doi:10.1111/febs.15654 · Cited by 12

CCL25 Signaling in the Tumor Microenvironment

Mir, H., & Singh, S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-62658-7_8 · Cited by 12

Intramuscular gene transfer of soluble B7.1/IgG1 fusion cDNA induces potent antitumor immunity as an adjuvant for DNA vaccination

Zhou, Z., Peretz, Y., Chang, Y., Miao, D., Li, X., & Prud’homme, G. J. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700595 · Cited by 12

Cell-based therapy approaches using dying cells: from tumour immunotherapy to transplantation tolerance induction

Saas, P., Tiberghien, P., & Bittencourt, M. D. C. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.3.249 · Cited by 12

Recombinant adenovirus-transduced human dendritic cells engineered to secrete interleukin-10 (IL-10) suppress Th1-type responses while selectively activating IL-10—producing CD4+ T cells

Réa, D., LaFace, D., Hutchins, B., Kwappenberg, K. M. C., Melief, C. J. M., Hoeben, R. C., & Offringa, R. (2004) · Human Immunology · doi:10.1016/j.humimm.2004.08.185 · Cited by 12

Using antibodies in tumour immunotherapy

Schultes, B. C., & Nicodemus, C. F. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.8.1265 · Cited by 12

Simultaneous enhancement of cellular and humoral immunity by the lymph node-targeted cholesterolized TLR7 agonist liposomes

Wan, D., Bai, Z., Zhang, Y., Chen, L., Que, H., Lan, T., Hong, W., Huang, J., Cai, H., Wei, Y., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.06.006 · Cited by 12

Adhesion to substrates induces dendritic cell endothelization and decreases immunological response

Osterbur, J., Sprague, L., Muccioli, M., Pate, M., Mansfield, K., McGinty, J. W., Li, Y., Li, Y., Shirure, V. S., Courreges, M. C., et al. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.02.003 · Cited by 11

Murine CD4+ T Cell Responses Are Inhibited by Cytotoxic T Cell-Mediated Killing of Dendritic Cells and Are Restored by Antigen Transfer

Ma, J. Z.-I., Lim, S. N., Qin, J., Yang, J., Enomoto, N., Ruedl, C., & Ronchese, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037481 · Cited by 11

Cross‐priming with an epicutaneously introduced soluble protein antigen generates Tc1 cells

Wang, L.-F., Hsu, C., Miaw, S., Chiu, H.-C., Liu, C.-Y., & Yu, H.-S. (2006) · European Journal of Immunology · doi:10.1002/eji.200535770 · Cited by 12

Mechanisms of occupational asthma caused by low-molecular-weight chemicals

Vooght, V. D., Hox, V., Nemery, B., & Vanoirbeek, J. A. (2010) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8556-9_9 · Cited by 11

Accumulation of CD8+ T Cells in Advanced-Stage Tumors and Delay of Disease Progression following Secondary Immunization against an Immunorecessive Epitope

Ryan, C. M., & Schell, T. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.255 · Cited by 11

Combinations of IFN-γand IL-4 induce distinct profiles of dendritic cell-associated immunoregulatory properties

Banyer, J., Halliday, D., Thomson, S. A., & Hamilton, N. H. R. (2003) · Genes and Immunity · doi:10.1038/sj.gene.6364005 · Cited by 11

Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection

Miller, D. S., Halpern, M. S., Kotlarski, I., & Jilbert, A. R. (2006) · Virology · doi:10.1016/j.virol.2005.12.032 · Cited by 11

Skin Dendritic Cells in Immunity and Autoimmunity

Udey, M. C. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1111/j.1087-0024.2004.00838.x · Cited by 11

Alterations of costimulatory molecules and instructive cytokines expressed by dendritic cells in the microenvironment of an endogenous mouse lymphoma

Naujoks, M., Weiß, J. V., Riedel, T., Hömberg, N., Przewoznik, M., Noeßner, E., Röcken, M., & Mocikat, R. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1538-7 · Cited by 11

Induction of HLA-A2-restricted CTL responses by a tubular structure carrying human melanoma epitopes

Ghosh, M. K., Li, C.-L., Fayolle, C., Dadaglio, G., Murphy, A., Lemonnier, F. A., Roy, P., & Leclerc, C. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00185-8 · Cited by 11

Immunogenic potential of irradiated lymphoma cells is enhanced by adjuvant immunotherapy and modulation of local macrophage populations

Honeychurch, J., Melis, M. H. M., Dovedi, S. J., Mu, L., & Illidge, T. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.769219 · Cited by 10

The pathogenicity of self-antigen decreases at high levels of autoantigenicity: a computational approach

Khadra, A., Santamaría, P., & Leah Edelstein-keshet, A. (2010) · International Immunology · doi:10.1093/intimm/dxq041 · Cited by 10

Identification of an HLA-A*0201-restricted epitopic peptide from human dystrophin: application in duchenne muscular dystrophy gene therapy

Ginhoux, F., Doucet, C., Leboeuf, M., Lemonnier, F. A., Danos, O., Davoust, J. M., & Firat, H. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00179-5 · Cited by 10

Immunotherapy of acute myeloid leukaemia: development of a whole cell vaccine

Adam, T. C. C. (2007) · Frontiers in bioscience · doi:10.2741/2820 · Cited by 10

Endolysosomal Processing of Exogenous Antigen into Major Histocompatibility Complex Class I‐Binding Peptides

Chen, L., & Jondal, M. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2004.01426.x · Cited by 10

Switching from a restricted to an effective CD4 T cell response by activating CD8+ murine dendritic cells with a Toll-like receptor 9 ligand

Rizzitelli, A., Vremec, D., Villadangos, J. A., Mavaddat, N., Wright, M. D., & Shortman, K. (2005) · European Journal of Immunology · doi:10.1002/eji.200526231 · Cited by 10

The show and tell of cross-presentation

Blander, J. M., Mon, K. J. Y., Jha, A., & Roycroft, D. (2023) · Advances in immunology · doi:10.1016/bs.ai.2023.08.002 · Cited by 9

Tuning Cross-Presentation of Apoptotic T Cells in Immunopathology

Barnaba, V. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-6217-0_3 · Cited by 9

Self-encounters of the third kind: lymph node stroma promotes tolerance to peripheral tissue antigens

Collier, A. Y., Lee, J., & Turley, S. J. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.19 · Cited by 9

A replication-incompetent CD154/40L recombinant vaccinia virus induces direct and macrophage-mediated antitumor effects in vitro and in vivo

Governa, V., Brittoli, A., Mele, V., Pinamonti, M., Terracciano, L., Muenst, S. E., Iezzi, G., Spagnoli, G. C., Zajac, P., & Trella, E. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1568162 · Cited by 9

T-cell-based immunotherapy of melanoma: what have we learned and how can we improve?

Campoli, M. R., & Ferrone, S. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.2.171 · Cited by 9

Spontaneous recovery from early glomerular inflammation is associated with resistance to anti-GBM glomerulonephritis: tolerance and autoimmune tissue injury

Robertson, J. M., Wu, J. G., Arends, J., Zhou, C., Adrogué, H. E., Chan, J. T., & Lou, Y. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.10.004 · Cited by 9

Basic overview of current immunotherapy approaches in urologic malignancy

Drake, C. G. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.08.013 · Cited by 9

Tumor resistance to CD8+ T cell-based therapeutic vaccination

Huang, Y., Shah, S., & Qiao, L. (2007) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-007-0029-3 · Cited by 9

Immune Response to Premalignancy: Insights from Patients with Monoclonal Gammopathy

Dhodapkar, M. V. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1358.004 · Cited by 9

Dendritic cell populations in patients with self-reported food hypersensitivity

Lied, G. A., Vogelsang, P., Berstad, A., & Appel, S. (2011) · International Journal of General Medicine · doi:10.2147/ijgm.s17655 · Cited by 9

Adjuvant effect of bovine heat shock protein 70 on piroplasm surface protein, p33, of Theileria sergenti

Jeong, W., Kweon, C. H., Kang, S. W., Lee, H. S., Ying-tian, X., Lu, C., Zhang, S., & Nene, V. M. (2009) · Biologicals · doi:10.1016/j.biologicals.2009.04.003 · Cited by 9

Identification of genes which regulate stroma-dependent in vitro hematopoiesis

Periasamy, P., Tran, V., & O'Neill, H. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205583 · Cited by 9

Development of a recombinant vaccine against foot and mouth disease utilizing mutant attenuated Listeria ivanovii strain as a live vector

MAHDY, S. E., Liu, S., Lin, S., Xiang, Z., Chen, H.-T., Xiaofang, P., & Wang, C. (2019) · Journal of Virological Methods · doi:10.1016/j.jviromet.2019.113722 · Cited by 9

Enhanced Levels of Costimulation Lead to Reduced Effector/Memory CD8+ T Cell Functionality

Mostböck, S., Vidal, S., Schlom, J., & Sabzevari, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3524 · Cited by 9

Proteasome is required for class I-restricted presentation by Fcγ receptor-mediated endocytosis in primary biliary cirrhosis

Kita, H., Ansari, A. A., He, X.-S., Lian, Z., de Water, J. V., Coppel, R. L., Luketic, V. A., Kaplan, M., Inamori, H., Isoda, N., et al. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00089-1 · Cited by 9

Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia

Allgeier, T., Garhammer, S., Nößner, E., Wahl, U., Kronenberger, K., Dreyling, M. H., Hallek, M. J., & Mocikat, R. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.01.019 · Cited by 9

Mechanisms Inducing or Controlling CD8+ T Cell Responses against Self‐ or Non‐Self‐Antigens

Accapezzato, D., Francavilla, V., Propato, A., Paroli, M., & Barnaba, V. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb06037.x · Cited by 9

Immune Escape

Whiteside, T. L., Campoli, M. R., & Ferrone, S. (2005) · Springer eBooks · doi:10.1007/1-4020-3623-x_3 · Cited by 9

Challenges and opportunities in analyzing and modeling peptide presentation by HLA-II proteins

ElAbd, H., Bächer, P., Tholey, A., Lenz, T. L., & Franke, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1107266 · Cited by 8

Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)

Mandalà, M., Galli, F., Patuzzo, R., Maurichi, A., D, S. M. M., Rossi, C. R., Rulli, E., Montesco, M. C., Quaglino, P., Caliendo, V., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.07.001 · Cited by 8

Flt3 ligand expands dendritic cell numbers in normal and malignant murine prostate

Moghaddami, M., Swart, B., Reynolds, P., Diener, K. R., & Brown, M. P. (2002) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2002.01100.x · Cited by 8

In Vivo Suppression of Heat Shock Protein (HSP)27 and HSP70 Accelerates DMBA-Induced Skin Carcinogenesis by Inducing Antigenic Unresponsiveness to the Initiating Carcinogenic Chemical

Yusuf, N., Nasti, T. H., Ahmad, I., Chowdhury, S., Mohiuddin, H., Xu, H., Athar, M., Timares, L., & Elmets, C. A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402804 · Cited by 9

Parvovirus H-1-Induced Tumor Cell Death Enhances Human Immune Response In Vitro via Increased Phagocytosis, Maturation, and Cross-Presentation by Dendritic Cells

Moehler, M. H., Zeidler, M., Wilsberg, V., Cornelis, J. J., Woelfel, T., Rommelaere, J., Galle, P. R., & Heike, M. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.ft-92 · Cited by 8

N-Terminal Trimer Extension of Nominal CD8 T Cell Epitopes Is Sufficient to Promote Cross-Presentation to Cognate CD8 T Cells In Vivo

Wei, C., & Sherman, L. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8280 · Cited by 8

Role of CD4 T lymphocytes in antitumor immunity

Rajnavölgyi, É., & Lányi, Á. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)87209-3 · Cited by 8

Role of CD4+ T lymphocytes in antitumor immunity

Rajnavölgyi, É., & Lányi, Á. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)87298-6 · Cited by 8

Tumor Suppressor Adenomatous Polyposis Coli Sustains Dendritic Cell Tolerance through IL-10 in a β-Catenin–Dependent Manner

Cao, W., Liu, J., Jiang, Z., Tao, Y., Wang, H., Li, J., Ni, J., & Wu, X. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300046 · Cited by 7

Viral Vectors for Vaccine Development

Qiana, L., Gu, L., Krendelchtchikov, A., & Zan, C. (2013) · InTech eBooks · doi:10.5772/54700 · Cited by 7

Immunomodulatory Effects of Hypocrellin A on MHC-restricted Antigen Processing

Park, S., Im, S., Kim, K., & Lee, C. (2011) · Immune Network · doi:10.4110/in.2011.11.6.412 · Cited by 7

Making use of the primary tumour

Baars, A., Buter, J., & Pinedo, H. M. (2002) · BioEssays · doi:10.1002/bies.10194 · Cited by 7

DC therapy for metastatic melanoma

Ingram, S. B., & OʼRourke, M. G. E. (2004) · Cytotherapy · doi:10.1080/14653240410005627 · Cited by 7

Dynamic Control of Self-Specific CD8+ T Cell Responses via a Combination of Signals Mediated by Dendritic Cells

Raveney, B. J. E., & Morgan, D. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2870 · Cited by 7

Isolation and propagation of human dendritic cells

Palucka, K., Banchereau, J., Caux, C., Dezutter‐Dambuyant, C., & Liu, Y.-J. (2002) · Methods in microbiology · doi:10.1016/s0580-9517(02)32106-8 · Cited by 7

Purification of the subcellular compartment in which exogenous antigens undergo endoplasmic reticulum-associated degradation from dendritic cells

Imai, J., Otani, M., Sakai, T., & Hatta, S. (2016) · Heliyon · doi:10.1016/j.heliyon.2016.e00151 · Cited by 7

The Many Sounds of T Lymphocyte Silence

Melero, I., Arina, A., & Chen, L. (2005) · Immunologic Research · doi:10.1385/ir:33:2:135 · Cited by 7

Immunotherapy of human papillomavirus-associated malignancies and the challenges posed by T-CELL tolerance

Ryan, A. W. (2002) · Frontiers in bioscience · doi:10.2741/wilcox · Cited by 7

Hematopoietic growth factors, dendritic cell biology, and vaccine therapy of cancer

Fay, J. W. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200205000-00005 · Cited by 7

Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer Immunotherapy

Xing, H., & Li, X. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202400425 · Cited by 6

Potent in vivo anti-tumor activity of isolated CD62Llow lymph node cells sensitized in vivo with tumor lysate-pulsed DC-based vaccines

Liu, Z., Fan, H., Wu, Y., & Chen, B. (2005) · Cytotherapy · doi:10.1080/14653240500241925 · Cited by 6

Brefeldin A inhibits vesicular MHC class I processing in resting but not in CpG- and disruption-activated DC

Chen, L., & Jondal, M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.07.018 · Cited by 6

Alloantigen specific deletion of primary human T cells by Fas ligand (CD95L)‐transduced monocyte‐derived killer‐dendritic cells

Schütz, C., Hoves, S., Halbritter, D., Zhang, H., Mountz, J. D., & Fleck, M. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03417.x · Cited by 6

Y in X priming

Amigorena, S. (2003) · Nature Immunology · doi:10.1038/ni1103-1047 · Cited by 6

Dendritic cell vaccination and immunostimulation in advanced melanoma

Ridolfi, R., Ridolfi, L., Petrini, M., Fiammenghi, L., & Riccobon, A. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.6.825 · Cited by 6

Immunology of the Testis and Male Reproductive Tract

Hedger, M. P. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01112-x · Cited by 6

Chemoimmunotherapeutic effect of combined treatment with ex vivo generated antigen-presenting immune cells and conventional antitumor agents in a mouse neuroblastoma model

Inoue, S., Setoyama, Y., Odaka, A., Kitagawa, D., & Beck, Y. (2017) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2017.04.006 · Cited by 6

More promiscuity resulting in more tolerance

Zehn, D., & Bevan, M. J. (2007) · Nature Immunology · doi:10.1038/ni0207-120 · Cited by 6

Comparative analysis of the fate of donor dendritic cells and B cells and their influence on alloreactive T cell responses under tacrolimus immunosuppression

Azhipa, O., Kimizuka, K., Nakao, A., Toyokawa, H., Okuda, T., Neto, J. S., Alber, S. M., Kaizu, T., Thomson, A. W., Demetris, A. J., et al. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.10.005 · Cited by 6

CCL16 Enhances the CD8 + and CD4 + T Cell Reactivity to Human Her-2 Elicited by Dendritic Cells Loaded with Rat Ortholog Her-2

Caorsi, C., Cappello, P., Ceruti, P., Amici, A. R. D., Marchini, C., Novelli, F., Forni, G., & Giovarelli, M. (2008) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200802100411 · Cited by 6

Immunotherapy and Cancer Therapeutics: Why Partner?

Emens, L. A., & Jaffee, E. M. (2007) · Elsevier eBooks · doi:10.1016/b978-012372551-6/50076-6 · Cited by 6

Parvovirus H-1-Induced Tumor Cell Death Enhances Human Immune Response In Vitro via Increased Phagocytosis, Maturation, and Cross-Presentation by Dendritic Cells

Moehler, M. H., Zeidler, M., Wilsberg, V., Cornelis, J. J., Woelfel, T., Rommelaere, J., Galle, P. R., & Heike, M. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.ft-102 · Cited by 6

Mechanisms of CD8+ T cell peripheral tolerance to our own antigens

Paroli, M. (2005) · Frontiers in bioscience · doi:10.2741/1646 · Cited by 6

Soluble proteins and haptens on bone marrow‐derived dendritic cells are presented to host CD4 T cells in an MHC‐restricted manner

Olasz, E. B., Linton, J. T., & Katz, S. I. (2002) · International Immunology · doi:10.1093/intimm/14.5.493 · Cited by 5

Lectins Isolated from MushroomFomitella fraxineaEnhance MHC-restricted Exogenous Antigen Presentation

Kim, H., Cho, K.-M., Gerelchuluun, T., Lee, J.-S., Chung, K.-S., & Lee, C. (2007) · Immune Network · doi:10.4110/in.2007.7.4.197 · Cited by 5

Toll-like receptors targeting technology for the treatment of lymphoma

Batool, M., Anwar, M. A., & Choi, S.-D. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1233964 · Cited by 7

Application of Surface-Linked Liposomal Antigens to the Development of Vaccines That Induce Both Humoral and Cellular Immunity

Uchida, T., & Taneichi, M. (2014) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.67.235 · Cited by 5

Human Dendritic Cell Subsets

Ueno, H., Klechevsky, E., Palucka, A. K., & Banchereau, J. (2010) · Methods in microbiology · doi:10.1016/s0580-9517(10)37019-x · Cited by 5

Immune modulation with dendritic cells

Panoskaltsis, N., Reid, C. D. L., & Knight, S. C. (2004) · Transfusion Medicine · doi:10.1111/j.0958-7578.2004.0485.x · Cited by 5

The cytotoxic T lymphocyte response against a protein antigen does not decrease the antibody response to that antigen although antigen-pulsed B cells can be targets

Wang, W., & Golding, B. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.04.003 · Cited by 5

Vaccination therapy in malignant disease

Aloysius, M. M., Robins, R. A., Eremin, J., & Eremin, O. (2006) · The Surgeon · doi:10.1016/s1479-666x(06)80008-9 · Cited by 5

Should microchimerism turn into rejection prophylactics?

Pujal, J. M. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.79 · Cited by 5

Advances in molecular immunotoxicology of occupational asthma induced by low molecular weight chemicals.

Lutz, W., & Palczynski, C. M. (2003) · PubMed · Cited by 5

Designing Peptide Vaccines for Cellular Cross-Presentation

Endert, P. V. (2001) · Biologicals · doi:10.1006/biol.2001.0301 · Cited by 5

TLR9 Activation Increases TAP‐Independent Vesicular MHC Class I Processing In vivo

Chen, L., & Jondal, M. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02315.x · Cited by 4

Role of CD8+T-cell immunity in influenza infection: potential use in future vaccine development

Gruta, N. L. L., Kelso, A., Brown, L. E., Chen, W., Jackson, D. C., & Turner, S. J. (2009) · Expert Review of Respiratory Medicine · doi:10.1586/ers.09.44 · Cited by 4

Developing Immunologic Tolerance for Transplantation at the Fetal Stage

Zerón, H. M. (2011) · Immunotherapy · doi:10.2217/imt.11.142 · Cited by 4

The Potential Role of Moringa oleifera Lam. Leaf Proteins in Moringa Allergy by Functionally Activating Murine Bone Marrow-Derived Dendritic Cells and Inducing Their Differentiation toward a Th2-Polarizing Phenotype

Xi, C., Li, W., Liu, X., Xie, J., Li, S., Tian, Y., & Song, S. (2023) · Nutrients · doi:10.3390/nu16010007 · Cited by 6

Robust anti-tumor immunity and memory in Rag-1-deficient mice following adoptive transfer of cytokine-primed splenocytes and tumor CD80 expression

Ganesan, P. L., Alexander, S. I., Watson, D., Logan, G. J., Zhang, G. Y., & Alexander, I. E. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0339-7 · Cited by 4

N-terminal functional region of the invariant chain efficiently targets the binding of a CTL epitope to MHC class I molecules during cross-presentation

Wu, C., Zhang, D. G., Chen, F. F., Liu, X. L., Liu, S. J., & Yu, W. (2014) · Genetics and Molecular Research · doi:10.4238/2014.april.3.16 · Cited by 4

Tolerance and autoimmunity in the eye: a role for CD8 T cells in organ‐specific autoimmunity in the retina

Forrester, J. V., & Cornall, R. J. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01774.x · Cited by 4

Cross-presentation by dendritic cells

Joffre, O. P., Segura, É., Savina, A., & Amigorena, S. (2012) · Nature reviews. Immunology · doi:10.1038/nri3254 · Cited by 1,764

Regulation of Antigen Presentation and Cross-Presentation in the Dendritic Cell Network: Facts, Hypothesis, and Immunological Implications

Wilson, N. S., & Villadangos, J. A. (2005) · Advances in immunology · doi:10.1016/s0065-2776(04)86007-3 · Cited by 181

Cross‐presentation: underlying mechanisms and role in immune surveillance

Rock, K. L., & Shen, L. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00301.x · Cited by 469

The evolving biology of cross-presentation

Ohara, R. A., & MURPHY, K. M. M. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101711 · Cited by 37

Cross-Presentation of Antigens by Dendritic Cells

Heath, W. R., Carbone, F., & Belz, G. T. (2002) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v22.i5-6.50 · Cited by 70